Oral Cancer clinical trials

Explore recruiting oral cancer clinical trials.

Recruiting oral cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oral Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Guided by Light: Optimizing Surgical Excision of Oral Cancer Using Real-time Fluorescence Imaging

Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Sentinel lymph node (SLN) detection in early oral cancer using Gallium-68-Tilmanocept PET/CT.

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Tolerability and efficacy of treating locally advanced Resectable Oral Cancer with neoadjuvant INtratumoral anti-CTLA4 ImmunoTherapy combined with systemic anti-PD-1 (ROCinIT).

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

NOCANO: Nivolumab as neoadjuvant immunotherapy for patients with Oral CANcer and identification of response-predictive biomarkers in tumour draining lymph NOdes

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

ImmunotherApy for the Prevention of High-Risk Oral DIsorders malignanT transformation - APHRODITE trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

IMCISION: Towards organ preservation and cure via ultra-short immunotherapy in advanced oral cancer. The IMCISION II trial, an investigator-initiated multicentre randomised phase 3 trial (M24IMS)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Oral Cancer trials by city

Oral Cancer in Toronto Oral Cancer in Vancouver Oral Cancer in Montreal Oral Cancer in Calgary Oral Cancer in Edmonton Oral Cancer in Ottawa Oral Cancer in Winnipeg Oral Cancer in Quebec City Oral Cancer in Hamilton Oral Cancer in Kitchener Oral Cancer in London Oral Cancer in Halifax Oral Cancer in New York Oral Cancer in Los Angeles Oral Cancer in Chicago Oral Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease